Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04191772
Other study ID # EXIMS
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2020
Est. completion date June 30, 2021

Study information

Verified date August 2021
Source Hasselt University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The current study aims to investigate whether persons with Multiple Sclerosis (PwMS) compensate training time with more sedentary time and consequently blunt training effects. The second aim will be to investigate the effect of a structured training program on specific brain volumes and cognitive variables.


Description:

Multiple Sclerosis is a progressive, autoimmune, neurodegenerative disorder of the central nervous system (CNS) that predominantly affects young to middle-aged adults. It is characterized by a chronic inflammatory process that causes demyelination, axonal damage and white matter lesions across the CNS. Furthermore, evidence also indicates grey matter (GM) atrophy which has been reported to be significantly correlated with both clinical and cognitive deterioration. Clinical manifestations include spasticity, tremor, paralysis, walking difficulties and cognitive abnormalities. Due to these primary disease symptoms, persons with MS (PwMS) appear to be susceptible to a sedentary lifestyle and inactivity, which consequently increases the risk of other important, health-related secondary deficits including respiratory, metabolic and cardiac dysfunction. These deficits further contribute to a decrease in cardiorespiratory fitness and quality of life (QoL), thereby causing a vicious circle of decreased exercise tolerance, greater disability and increased inactivity. Since pharmacological treatment has little impact on these secondary deficits, exercise therapy has become an important aspect of the treatment of MS. Hence, exercise therapy interventions in MS have been studied extensively and have already been proven to significantly improve cardiorespiratory fitness, muscle strength, balance, fatigue, cognition, quality of life, respiratory function and brain volumes. Moreover, a dose-response relationship has been reported for functional variables such as strength and endurance capacity. As such, high intensity interval training (HIIT) probably is exerts superior effects compared to traditional low/moderate intensity continuous training (MICT). However and in contrast with other populations, effects of HIIT on important health-related variables such as body composition, blood pressure and blood lipid profiles are less evident. Possibly, PwMS do not reach the exercise intensities required to improve such factors due to cardiovascular autonomic dysfunction, leading to impaired carotid baroreflex control, attenuated elevations in blood pressure and disturbed increases in heart rate, and abnormal muscle energy metabolism. Moreover, higher intensities might hamper longer-term implementation in real life, as an inverse relation between exercise intensity and training adherence has already been reported. Training periodization (alternating HIIT and MICT) offers a solution to overcome the barrier of adherence and concurrently augmenting training effects, but in contrast to other populations, the addition of a lower intensity training component does still not improve health-related variables. Therefore, other approaches are warranted. Recently, evidence is growing that sedentary time is an important health risk factor, independent of the (dis)practice of structured exercise. Hence, PwMS possibly compensate training effects with even more sedentary time, in addition to an already sedentary lifestyle as mentioned previously. As such, addressing sedentary time might be an interesting new approach to counteract the health-related deficits in PwMS. Therefore, the present study explores the impact of a structured exercise program on sedentary time and health-related variables. Furthermore, a secondary aim of the current project is to investigate the effect of a periodized training program on brain volumes and cognitive function. Recent evidence of physical training effects on cognitive variables is contradictory. So for exercise intervention studies that studied the latter only used short-term and laboratory-based training programs and included exercise modalities (type, intensity, duration) that are difficult to compare. Interestingly, a recent short-term randomized controlled trial reported superior effects of HIIT on cognitive functions compared to MICT. Hence, the current study aims to investigate the impact of a long-term, home-based training program with HIIT-components on cognitive variables.


Recruitment information / eligibility

Status Completed
Enrollment 156
Est. completion date June 30, 2021
Est. primary completion date June 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Multiple Sclerosis according to the McDonald criteria (Relaps remitting) - Written informed consent - Medical safety screening Exclusion Criteria: - Contra-indications to participate in moderate to high intensity exercise - Contra-indications to undergo magnetic resonance imaging (pacemaker/defibrillator or wires other than sternal wires, insulin pumps, metal foreign bodies, deep brain stimulator, cerebral aneurysm clips, cochlear implant, magnetic dental implant, drug infusion device) - Medication changes in the last month before the start of the intervention - Following or plan to follow a weight reduction program - Pregnancy - Participation in another study - Acute MS exacerbation < 3 months prior to the start of the study - EDSS score > 4 - Consumption of more than 20 alcohol units/week - No daily internet access

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Periodized, home-based running program
All participants will perform a home-based supervised exercise training program. Participants will receive weekly training instructions using a smartphone-based heart rate monitor application (Polar® app). Training sessions will involve running and the design of the training program will be based on linear periodization, where aerobic capacity is built firstly through a period of high-volume/low-intensity training before the proportion of high-intensity training is increased. The total duration of the exercise program will be 12 months with three weekly training sessions. Training progression will be dependent on initial VO2max values and running experience. VO2max classification is based on reference values described in V.H. Heyward, Advanced Fitness Assessment and Exercise Prescription, Fifth Edition, 2006, Champaign, IL: Human Kinetics.

Locations

Country Name City State
Belgium Hasselt University Diepenbeek Limburg

Sponsors (1)

Lead Sponsor Collaborator
Hasselt University

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of steps per day Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Before start of the training program
Primary Number of steps per day Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 1 of the training program
Primary Number of steps per day Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 24 of the training program
Primary Number of steps per day Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 48 of the training program
Primary Number of steps per day Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). 3 months after the training program
Primary Sitting time Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Before start of the training program
Primary Sitting time Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 1 of the training program
Primary Sitting time Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 24 of the training program
Primary Sitting time Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 48 of the training program
Primary Sitting time Sedentary behaviour will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). 3 months after the training program
Primary Standing time Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Before start of the training program
Primary Standing time Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 1 of the training program
Primary Standing time Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 24 of the training program
Primary Standing time Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 48 of the training program
Primary Standing time Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). 3 months after the training program
Primary Stepping time Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Before start of the training program
Primary Stepping time Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 1 of the training program
Primary Stepping time Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 24 of the training program
Primary Stepping time Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). Week 48 of the training program
Primary Stepping time Physical activity will be measured with the ActivPAL3TM activity monitor (PAL Technologies Ltd, Glasgow, UK). 3 months after the training program
Secondary Blood pressure Systolic, diastolic and mean arterial blood pressure will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements. Baseline
Secondary Blood pressure Systolic, diastolic and mean arterial blood pressure will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements. Week 48 of the training program
Secondary Resting heart rate Resting heart rate will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements. Baseline
Secondary Resting heart rate Resting heart rate will be measured 4 times at 5-min intervals after an initial resting period of 10min, using an electronic sphygmomanometer (Omron®, Omron Healthcare, IL, USA) from the dominant arm and documented as the mean value of the final 3 measurements. Week 48 of the training program
Secondary Total calorie intake Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated. Baseline
Secondary Total calorie intake Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated. Week 12 of the training program
Secondary Total calorie intake Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated. Week 24 of the training program
Secondary Total calorie intake Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated. Week 48 of the training program
Secondary Total calorie intake Participants will record all food and beverages consumed over seven consecutive days and from this the total calorie intake is calculated. 3 months after the training program
Secondary Macronutrient content Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated. Baseline
Secondary Macronutrient content Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated. Week 12 of the training program
Secondary Macronutrient content Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated. Week 24 of the training program
Secondary Macronutrient content Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated. Week 48 of the training program
Secondary Macronutrient content Participants will record all food and beverages consumed over seven consecutive days and from this the macronutrient content is calculated. 3 months after the training program
Secondary Participation - Ghent Participation Scale (GPS) The GPS is a generic instrument including both objective and all relevant subjective variables resulting in one score, already proven to be valid to rate participation in MS. Baseline
Secondary Participation - Ghent Participation Scale (GPS) The GPS is a generic instrument including both objective and all relevant subjective variables resulting in one score, already proven to be valid to rate participation in MS. Week 48 of the training program
Secondary Mobility - MS walking scale (MSWS-12) The MSWS-12 is a 12-item self-assessment scale which measures the impact of MS on mobility, which showed the ability of a running program to reduce impact of MS on walking ability in a previous pilot RCT by our research group Baseline
Secondary Mobility - MS walking scale (MSWS-12) The MSWS-12 is a 12-item self-assessment scale which measures the impact of MS on mobility, which showed the ability of a running program to reduce impact of MS on walking ability in a previous pilot RCT by our research group Week 48 of the training program
Secondary Fatigue - Modified Fatigue Impact scale (MFIS) To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed. Before start of the intervention
Secondary Fatigue - Modified Fatigue Impact scale (MFIS) To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed. Week 1 of the intervention
Secondary Fatigue - Modified Fatigue Impact scale (MFIS) To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed. Week 12 of the training program
Secondary Fatigue - Modified Fatigue Impact scale (MFIS) To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed. Week 24 of the training program
Secondary Fatigue - Modified Fatigue Impact scale (MFIS) To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed. Week 48 of the training program
Secondary Fatigue - Modified Fatigue Impact scale (MFIS) To evaluate the impact of structured training on fatigue, the Modified Fatigue Impact Scale (MFIS) will be used, which is the recommended questionnaire for research related to fatigue by the Multiple Sclerosis Council for Clinical guidelines. In the MFIS, the perceived impact of fatigue on physical, cognitive and psychosocial functioning of the past 4 weeks is assessed. 3 months after the training program
Secondary Cognition - Spatial Recall test (SPART) The SPART is a visuospatial learning and delayed recall test, where a checkerboard with seven checkers in specified places is presented for 10sec to the participants who have to place the checkers back on a blank checkerboard immediately after and after another 30min. The total score is a sum of the correct checkers. This has been shown to be one of the most sensitive measures for detecting memory impairments in PwMS and showed improved performance after a running program in a previous pilot RCT of our research group Baseline
Secondary Cognition - Spatial Recall test (SPART) The SPART is a visuospatial learning and delayed recall test, where a checkerboard with seven checkers in specified places is presented for 10sec to the participants who have to place the checkers back on a blank checkerboard immediately after and after another 30min. The total score is a sum of the correct checkers. This has been shown to be one of the most sensitive measures for detecting memory impairments in PwMS and showed improved performance after a running program in a previous pilot RCT of our research group Week 48 of the training program
Secondary Cognition - Symbol Digit Modalities Test (SDMT) The SDMT is a test of information processing speed (PS) in which participants need to combine as many symbols with the accompanying numbers as possible in 90 seconds. The SDMT has been found to be a reliable and valid test in MS and a responder definition of approximating 4 points or 10% in magnitude SDMT change was recommended. Baseline
Secondary Cognition - Symbol Digit Modalities Test (SDMT) The SDMT is a test of information processing speed (PS) in which participants need to combine as many symbols with the accompanying numbers as possible in 90 seconds. The SDMT has been found to be a reliable and valid test in MS and a responder definition of approximating 4 points or 10% in magnitude SDMT change was recommended. Week 48 of the training program
Secondary Body weight Body weight is determined using a digital-balanced weighting scale to the nearest 0.1kg Baseline
Secondary Body weight Body weight is determined using a digital-balanced weighting scale to the nearest 0.1kg Week 48 of the training program
Secondary Height Body height is measured to the nearest 0.1cm using a wall-mounted Harpenden stadiometer, with participants barefoot Baseline
Secondary Height Body height is measured to the nearest 0.1cm using a wall-mounted Harpenden stadiometer, with participants barefoot Week 48 of the training program
Secondary DEXA (Dual Energy X-Ray) body fat mass and lean tissue mass using Dual Energy X-ray Absorptiometry Baseline
Secondary DEXA (Dual Energy X-Ray) body fat mass and lean tissue mass using Dual Energy X-ray Absorptiometry Week 48 of the training program
Secondary Coordination - timed tandem walk (TTW) Participants will have to walk in a straight line with one foot immediately in front of the other (heel to toe), while the arms are kept down at the side. Time to complete 3 meter will be monitored. Baseline
Secondary Coordination - timed tandem walk (TTW) Participants will have to walk in a straight line with one foot immediately in front of the other (heel to toe), while the arms are kept down at the side. Time to complete 3 meter will be monitored. Week 48 of the training program
Secondary Oxygen uptake (VO2) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VO2 is collected breath-by-breath and averaged every ten seconds. Baseline
Secondary Oxygen uptake (VO2) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VO2 is collected breath-by-breath and averaged every ten seconds. Week 48 of the training program
Secondary Carbon dioxide output (VCO2) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VCO2 is collected breath-by-breath and averaged every ten seconds. Baseline
Secondary Carbon dioxide output (VCO2) Cardiopulmonary exercise test on on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VCO2 is collected breath-by-breath and averaged every ten seconds. Week 48 of the training protocol
Secondary Minute ventilation (VE) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE is collected breath-by-breath and averaged every ten seconds. Baseline
Secondary Minute ventilation (VE) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE is collected breath-by-breath and averaged every ten seconds. Week 48 of the training protocol
Secondary Equivalents for oxygen uptake (VE/VO2) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VO2 is collected breath-by-breath and averaged every ten seconds. Baseline
Secondary Equivalents for oxygen uptake (VE/VO2) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VO2 is collected breath-by-breath and averaged every ten seconds. Week 48 of the training protocol
Secondary Equivalents for carbon dioxide production (VE/VCO2) Cardiopulmonary exercise test on on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VCO2 is collected breath-by-breath and averaged every ten seconds. Baseline
Secondary Equivalents for carbon dioxide production (VE/VCO2) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE/VCO2 is collected breath-by-breath and averaged every ten seconds. Week 48 of the training program
Secondary Tidal volume (Vt) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis Vt is collected breath-by-breath and averaged every ten seconds. Baseline
Secondary Tidal volume (Vt) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis Vt is collected breath-by-breath and averaged every ten seconds. Week 48 of the training program
Secondary Breathing frequency (BF) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis BF is collected breath-by-breath and averaged every ten seconds. Baseline
Secondary Breathing frequency (BF) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis BF is collected breath-by-breath and averaged every ten seconds. Week 48 of the training protocol
Secondary Respiratory gas exchange ratio (RER) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis RER is collected breath-by-breath and averaged every ten seconds. Baseline
Secondary Respiratory gas exchange ratio (RER) Cardiopulmonary exercise test on a bicycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis RER is collected breath-by-breath and averaged every ten seconds. Week 48 of the training program
Secondary Cardiorespiratory fitness (CRF) CRF will be measured with a maximal cardiopulmonary exercise test on a bicycle ergometer. Baseline
Secondary Cardiorespiratory fitness (CRF) CRF will be measured with a maximal cardiopulmonary exercise test on a bicycle ergometer. Week 48 of the training program
Secondary Lipidomic profile Blood analysis Baseline
Secondary Lipidomic profile Blood analysis Week 48 of the training program
Secondary Brain volumes MRI scan Baseline
Secondary Brain volumes MRI scan Week 48 of the training program
Secondary PBMC subset parameters flow cytometry analysis of immune cell subsets in peripheral blood-derived mononuclear cells (PBMCs) Baseline
Secondary PBMC subset parameters flow cytometry analysis of immune cell subsets in peripheral blood-derived mononuclear cells (PBMCs) Week 48 of the training program
Secondary serum cytokines cytokine levels are measured by ELISA on serum derived from peripheral blood samples Baseline
Secondary serum cytokines cytokine levels are measured by ELISA on serum derived from peripheral blood samples Week 48 of the training program
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis